Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection
- 31 March 2003
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 24 (3) , 131-138
- https://doi.org/10.1016/s0165-6147(03)00028-2
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- New concepts in the immunopathogenesis of multiple sclerosisNature Reviews Neuroscience, 2002
- Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapyTrends in Molecular Medicine, 2001
- The Neuroimmunology of Multiple Sclerosis: Possible Roles of T and B Lymphocytes in ImmunopathogenesisJournal of Clinical Immunology, 2001
- Multiple SclerosisNew England Journal of Medicine, 2000
- The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosisJournal of Neuroimmunology, 2000
- Therapeutic developments in multiple sclerosisExpert Opinion on Investigational Drugs, 2000
- Innate and adaptive immune responses can be beneficial for CNS repairTrends in Neurosciences, 1999
- Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectivesBrain, 1997
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosisNeurology, 1993